Last 12 months
Inside the activity.
27 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 17 | 0 |
| Jun 2026 | 10 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 11, 2026 20:33 UTC |
Edwards Jeffrey W.Director · President, CEO and Chairman · 10% owner
|
GiftCommon Stock, $0.01 par value per share | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-061572 · wk-form4_1789158791.xml · nonDerivative · entry 1 Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,803 F1 · kind: Gift to a charitable organization. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:30 UTC |
Jackson Janet E.Director
|
SaleCommon Stock, $0.01 par value per share | 1,086 | $237.06 | $257,447.16 |
DisclosureSEC source: 0001628280-26-060927 · wk-form4_1788899423.xml · nonDerivative · entry 1 Jackson Janet E. · CIK 0001599712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,142 Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 155 | $206.74 | $32,044.70 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 10 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,209 F9 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $206.5250 to $207.0400. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 80 | $205.52 | $16,441.60 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 9 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,054 F8 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $204.9900 to $205.9500. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 20 | $204.32 | $4,086.40 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 8 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,974 F7 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $203.9100 to $204.7300. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 99 | $202.73 | $20,070.27 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 7 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,954 F6 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $202.4100 to $203.2123. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 133 | $201.91 | $26,854.03 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 6 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,855 F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $201.3100 to $202.2750. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 1 | $200.03 | $200.03 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 5 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,722 Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 14 | $198.79 | $2,783.06 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 4 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,721 F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $198.4350 to $198.8410. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 145 | $197.55 | $28,644.75 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 3 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,707 F3 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $197.3791 to $198.0100. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 278 | $196.95 | $54,752.10 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 2 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,562 F2 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $196.3250 to $197.3100. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 11:15 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 65 | $195.89 | $12,732.85 |
DisclosureSEC source: 0001628280-26-043030 · wk-form4_1781522103.xml · nonDerivative · entry 1 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,284 F1 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $195.2738 to $196.2670. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:38 UTC |
Carter Margot LebenbergDirector
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036932 · wk-form4_1779309481.xml · nonDerivative · entry 1 Carter Margot Lebenberg · CIK 0001018430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,268 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:37 UTC |
Hilsheimer Lawrence A.Director
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036931 · wk-form4_1779309453.xml · nonDerivative · entry 1 Hilsheimer Lawrence A. · CIK 0001414433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,323 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:36 UTC |
MEUSE DAVID RDirector
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036928 · wk-form4_1779309371.xml · nonDerivative · entry 1 MEUSE DAVID R · CIK 0001223829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,602 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:34 UTC |
SCHOTTENSTEIN ROBERT HDirector
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036923 · wk-form4_1779309275.xml · nonDerivative · entry 1 SCHOTTENSTEIN ROBERT H · CIK 0001204731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,132 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:34 UTC |
THOMAS MICHAEL HDirector
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036922 · wk-form4_1779309254.xml · nonDerivative · entry 1 THOMAS MICHAEL H · CIK 0001251260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,228 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:36 UTC |
Jackson Janet E.Director
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036930 · wk-form4_1779309415.xml · nonDerivative · entry 1 Jackson Janet E. · CIK 0001599712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,228 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:35 UTC |
Moore Marchelle EDirector
|
GrantCommon Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036925 · wk-form4_1779309330.xml · nonDerivative · entry 1 Moore Marchelle E · CIK 0001976215 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,162 F1 · shares: The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:38 UTC |
Niswonger Jason RChief Admin. & Sustainability
|
GiftCommon Stock, $0.01 par value per share | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035156 · wk-form4_1778791078.xml · nonDerivative · entry 1 Niswonger Jason R · CIK 0001696709 · Chief Admin. & Sustainability 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,097 F1 · shares: Gift to a charitable organization. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:48 UTC |
Wheeler Brad AChief Operating Officer
|
PurchaseCommon Stock, $0.01 par value per share | 716 | $209.13 | $149,737.08 |
DisclosureSEC source: 0001628280-26-034261 · wk-form4_1778626092.xml · nonDerivative · entry 1 Wheeler Brad A · CIK 0002005602 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,988 Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:50 UTC |
Hilsheimer Lawrence A.Director
|
PurchaseCommon Stock, $0.01 par value per share | 475 | $206.22 | $97,952.13 |
DisclosureSEC source: 0001628280-26-034268 · wk-form4_1778626253.xml · nonDerivative · entry 1 Hilsheimer Lawrence A. · CIK 0001414433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,468 Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:50 UTC |
Niswonger Jason RChief Admin. & Sustainability
|
PurchaseCommon Stock, $0.01 par value per share | 455 | $214.80 | $97,734.00 |
DisclosureSEC source: 0001628280-26-034265 · wk-form4_1778626210.xml · nonDerivative · entry 1 Niswonger Jason R · CIK 0001696709 · Chief Admin. & Sustainability 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,122 Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 10 | $217.91 | $2,179.05 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 14 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,219 Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 110 | $217.46 | $23,920.60 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 13 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,209 F13 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $216.8600 to $217.8100. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 190 | $216.33 | $41,102.70 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 12 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,099 F12 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $215.8050 to $216.7450. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 30 | $215.24 | $6,457.20 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 11 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,909 F11 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $214.8000 to $215.2550. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 50 | $213.88 | $10,694.00 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 10 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,879 F10 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $213.5600 to $214.3100. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 20 | $212.75 | $4,255.00 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 9 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,829 F9 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $212.4521 to $213.0500. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 50 | $211.48 | $10,574.00 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 8 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,809 F8 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $211.2688 to $212.0960. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 40 | $210.58 | $8,423.20 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 7 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,759 F7 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $210.1400 to $211.0458. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 70 | $209.31 | $14,651.70 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 6 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,719 F6 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $209.0400 to $209.8300. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 110 | $208.43 | $22,927.30 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 5 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,649 F5 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $208.0250 to $208.9850. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 154 | $207.04 | $31,884.16 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 4 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,539 F4 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $206.8050 to $207.6850. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 802 | $206.06 | $165,260.12 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 3 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,385 F3 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $205.6250 to $206.5750. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 520 | $205.08 | $106,641.60 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 2 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,583 F2 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $204.6200 to $205.6100. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:49 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
PurchaseCommon Stock, $0.01 par value per share | 244 | $204.10 | $49,800.40 |
DisclosureSEC source: 0001628280-26-034263 · wk-form4_1778626158.xml · nonDerivative · entry 1 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,063 F1 · price: The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $203.5700 to $204.5366. The Reporting Person undertakes to provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:35 UTC |
Wheeler Brad AChief Operating Officer
|
Tax withholdingCommon Stock, $0.01 par value per share | 916 | $309.45 | $283,456.20 |
DisclosureSEC source: 0001628280-26-026315 · wk-form4_1776803708.xml · nonDerivative · entry 1 Wheeler Brad A · CIK 0002005602 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,272 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 2,330 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:37 UTC |
FRY TODD RChief Accounting Officer
|
Tax withholdingCommon Stock, $0.01 par value per share | 756 | $309.45 | $233,944.20 |
DisclosureSEC source: 0001628280-26-026323 · wk-form4_1776803852.xml · nonDerivative · entry 1 FRY TODD R · CIK 0001234942 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,697 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 1,698 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:37 UTC |
HIRE WILLIAM JEFFREYPresident of External Affairs
|
Tax withholdingCommon Stock, $0.01 par value per share | 2,844 | $309.45 | $880,075.80 |
DisclosureSEC source: 0001628280-26-026321 · wk-form4_1776803822.xml · nonDerivative · entry 1 HIRE WILLIAM JEFFREY · CIK 0001732519 · President of External Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,923 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 7,229 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:36 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
Tax withholdingCommon Stock, $0.01 par value per share | 3,361 | $309.45 | $1,040,061.45 |
DisclosureSEC source: 0001628280-26-026319 · wk-form4_1776803793.xml · nonDerivative · entry 1 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,819 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 8,544 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:34 UTC |
Edwards Jeffrey W.Director · President, CEO and Chairman · 10% owner
|
Tax withholdingCommon Stock, $0.01 par value per share | 11,214 | $309.45 | $3,470,172.30 |
DisclosureSEC source: 0001628280-26-026313 · wk-form4_1776803668.xml · nonDerivative · entry 1 Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,303 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 26,799 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 20:35 UTC |
Niswonger Jason RChief Admin. & Sustainability
|
Tax withholdingCommon Stock, $0.01 par value per share | 1,406 | $309.45 | $435,086.70 |
DisclosureSEC source: 0001628280-26-026317 · wk-form4_1776803743.xml · nonDerivative · entry 1 Niswonger Jason R · CIK 0001696709 · Chief Admin. & Sustainability 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 F1 · shares: Represents shares withheld to satisfy tax withholding obligation on vesting of 3,155 shares of restricted stock pursuant to the 2023 Omnibus Incentive Plan. Read SEC document |
| March 11, 2026 Filed Mar 11, 2026 20:42 UTC |
Miller Michael ThomasDirector · Executive VP & CFO
|
GiftCommon Stock, $0.01 par value per share | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016870 · wk-form4_1773261750.xml · nonDerivative · entry 1 Miller Michael Thomas · CIK 0001598873 · Director · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 26,420 F1 · shares: Reflects the gift of common stock to a charitable fund. F2 · ownership.nature: These shares are held by a trust of which Mr. Miller is the sole trustee and sole beneficiary and exercises sole voting and investment power. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:40 UTC |
Carter Margot LebenbergDirector
|
SaleCommon Stock, $0.01 par value per share | 2,000 | $299.31 | $598,620.00 |
DisclosureSEC source: 0001628280-26-016865 · wk-form4_1773261640.xml · nonDerivative · entry 1 Carter Margot Lebenberg · CIK 0001018430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,413 Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:41 UTC |
Hilsheimer Lawrence A.Director
|
GiftCommon Stock, $0.01 par value per share | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016868 · wk-form4_1773261693.xml · nonDerivative · entry 1 Hilsheimer Lawrence A. · CIK 0001414433 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,993 F1 · shares: Gift to a charitable organization. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:55 UTC |
Jackson Janet E.Director
|
SaleCommon Stock, $0.01 par value per share | 1,410 | $293.31 | $413,567.10 |
DisclosureSEC source: 0001628280-26-016886 · wk-form4_1773262521.xml · nonDerivative · entry 1 Jackson Janet E. · CIK 0001599712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,373 Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC |
Edwards Jeffrey W.Director · President, CEO and Chairman · 10% owner
Installed Building Systems, Inc.Director by Deputization
PJAM IBP Holdings, Inc.Director by Deputization
IBP Holding CoDirector by Deputization
|
OtherForward sale contract (potential obligation to sell) · Derivative | 125,000 | $314.06 Strike: $314.06 | $39,257,500.00 |
DisclosureSEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 8 Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization IBP Holding Co · CIK 0001610199 · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC |
Edwards Jeffrey W.Director · President, CEO and Chairman · 10% owner
Installed Building Systems, Inc.Director by Deputization
PJAM IBP Holdings, Inc.Director by Deputization
IBP Holding CoDirector by Deputization
|
OtherForward sale contract (potential obligation to sell) · Derivative | 125,000 | $314.06 Strike: $314.06 | $39,257,500.00 |
DisclosureSEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 7 Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization IBP Holding Co · CIK 0001610199 · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires not disclosed F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC |
Edwards Jeffrey W.Director · President, CEO and Chairman · 10% owner
Installed Building Systems, Inc.Director by Deputization
PJAM IBP Holdings, Inc.Director by Deputization
IBP Holding CoDirector by Deputization
|
OtherForward sale contract (potential obligation to sell) · Derivative | 225,000 | $314.06 Strike: $314.06 | $70,663,500.00 |
DisclosureSEC source: 0001628280-26-014669 · wk-form4_1772660274.xml · derivative · entry 6 Edwards Jeffrey W. · CIK 0001598688 · Director · President, CEO and Chairman · 10% owner Installed Building Systems, Inc. · CIK 0001609975 · Director by Deputization PJAM IBP Holdings, Inc. · CIK 0001609973 · Director by Deputization IBP Holding Co · CIK 0001610199 · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires not disclosed F5 · derivative.exercise_price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · derivative.exercise_price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · derivative.exercise_price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · derivative.exercise_price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · derivative.exercise_price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · kind: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · kind: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · kind: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · kind: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · kind: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F5 · price: As previously reported, IBS entered into two prepaid variable forward sale contracts on each of September 2023, November 2023 and May 2024 with an unaffiliated third party buyer. In each of the September and November transactions, IBS pledged 450,000 shares, or 225,000 shares per contract and 900,000 shares in the aggregate, and in the May transaction, IBS pledged 250,000 shares, or 125,000 shares per contract (collectively, the "Pledged Shares") of Installed Building Products, Inc. common stock ("Common Stock"). The Pledged Shares secure its obligations under the contracts, and IBS retained dividend and voting rights in the Pledged Shares during the term of the pledge. The contracts obligate IBS to deliver to the buyer, on the applicable settlement date for each component referred to in footnote 10 below, up to one hundred percent (100%) of the number of Pledged Shares for such component or, at IBS' option, an equivalent amount of cash. F6 · price: On August 12, 2025, IBS and the buyer entered into an amendment to the September 2023 forward sale contract and the May 2024 forward sale contract. On March 3, 2026, IBS and the buyer entered into a second amendment to the September 2023 forward sale contract (the "September Amendment Agreement") and the May 2024 forward sale contract (the "May Amendment Agreement" and collectively the "2026 Amendment Agreements"). The reference price for the 2026 Amendment Agreements was $314.06. The September Amendment Agreement amends certain terms of one of the forward sale contracts entered into in September 2023, covering 225,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, F7 · price: (Continued from footnote 6) (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustment for the number of shares to be delivered on the respective settlement date for each component. The May Amendment Agreement amends certain terms of one of the forward sale contracts entered into in May 2024, covering 125,000 shares of Common Stock, including (i) extending the range of settlement dates for the components from March 9, 2026 through March 13, 2026 to the new settlement dates from May 24, 2027 through June 4, 2027, (ii) amending the Floor Price (as defined below) and the Cap Price (as defined below), and (iii) increasing the number of components from 5 to 9, with appropriate adjustments for the number of shares to be delivered on the respective settlement date for each component. F8 · price: (Continued from footnote 7) The number of shares of Common Stock to be delivered to the buyer on the settlement date (or on which to base the amount of cash to be delivered to the buyer on such settlement date) under each Amendment Agreement is to be determined as follows: (a) if the VWAP of the Common Stock on the designated valuation date for the applicable component (each, a "Settlement Price") is less than or equal to $314.06 (the "Floor Price"), IBS will deliver to the buyer all of the Pledged Shares for the applicable component; F9 · price: (Continued from footnote 8) (b) if such Settlement Price is greater than the Floor Price but less than or equal to $376.872 (the "Cap Price"), IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price and the denominator of which is such Settlement Price; and (c) if such Settlement Price is greater than the Cap Price, IBS will deliver to the buyer the number of shares equal to 100% of the Pledged Shares for the applicable component multiplied by a fraction, the numerator of which is the Floor Price plus the excess of such Settlement Price over the Cap Price, and the denominator of which is such Settlement Price. F10 · derivative.exercise_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F10 · derivative.expiration_date: Each component is exercisable on the same date as it expires, and the expiration dates for the components occur from May 24, 2027 through June 4, 2027 under the 2026 Amendment Agreements. F11 · ownership.nature: These securities are held directly by IBS. Mr. Edwards disclaims beneficial ownership in the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.